2025 annual financial data

Ovid Therapeutics 2025 Net margin

Direct answer

Net margin was -240.13%.

Operating income was -42.44M USD and net income was -17.41M USD.
Operating cash flow was -38.33M USD.

Get free Ovid Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7.25M USD
Operating income
-42.44M USD
Net income
-17.41M USD
Operating cash flow
-38.33M USD